Display options
Share it on

Ren Fail. 2021 Dec;43(1):1146-1154. doi: 10.1080/0886022X.2021.1949347.

The landscape of renal replacement therapy in Veterans Affairs Medical Center intensive care units.

Renal failure

Chandan Vangala, Maulin Shah, Natasha N Dave, Layth Al Attar, Sankar D Navaneethan, Venkat Ramanathan, Susan Crowley, Wolfgang C Winkelmayer

Affiliations

  1. Baylor College of Medicine, Houston, TX, USA.
  2. Michael E. DeBakey Veterans Affairs Medical Center, Houston, TX, USA.
  3. Houston Center for Innovations in Quality, Effectiveness, and Safety (IQuESt), Houston, TX, USA.
  4. Yale School of Medicine, New Haven, CT, USA.
  5. Veterans Affairs Connecticut Healthcare System, West Haven, CT, USA.

PMID: 34261420 PMCID: PMC8280999 DOI: 10.1080/0886022X.2021.1949347

Abstract

RESULTS: Seventy-six centers completed the questionnaire, achieving a response rate of 87.4%. Fifty-five centers reported using PIRRT or CRRT in addition to intermittent hemodialysis. Of these centers, 42 reported being specifically CRRT-capable. Over half of respondents had the capabilities to perform PIRRT. Twelve centers (21.8%) were equipped to use slow low efficient dialysis (SLED) alone. Therapy was largely prescribed by nephrologists (94.4% of centers).

CONCLUSIONS: Within the VA system, ICU-related RRT practice is quite varied. Variation in processes of care, prescription authority, nursing care coordination, medication management, and safety practices present opportunities for developing cross-cutting measures of quality of intensive care RRT that are agnostic of modality choice.

Keywords: CRRT; Continuous renal replacement therapy; PIRRT; intensive care unit; prolonged intermittent renal replacement therapy; veterans affairs

References

  1. Cochrane Database Syst Rev. 2016 Apr 04;4:CD009631 - PubMed
  2. JAMA. 2020 Oct 27;324(16):1629-1639 - PubMed
  3. Hemodial Int. 2009 Apr;13(2):205-14 - PubMed
  4. Ann Intensive Care. 2019 Jul 1;9(1):75 - PubMed
  5. Clin Nephrol. 2016 Jul;86(7):43-50 - PubMed
  6. Am J Kidney Dis. 2012 Jun;59(6):810-8 - PubMed
  7. J Clin Pharmacol. 2016 Oct;56(10):1277-87 - PubMed
  8. Nutr Clin Pract. 2005 Apr;20(2):176-91 - PubMed
  9. Am J Nephrol. 2016;43(4):261-70 - PubMed
  10. Clin Infect Dis. 2005 Oct 15;41(8):1159-66 - PubMed
  11. Vital Health Stat 11. 2012 Oct;(252):1-48 - PubMed
  12. N Engl J Med. 2008 Jul 3;359(1):7-20 - PubMed
  13. J Crit Care. 2017 Oct;41:138-144 - PubMed
  14. PLoS One. 2017 May 24;12(5):e0177759 - PubMed
  15. Int J Artif Organs. 2002 Apr;25(4):261-8 - PubMed
  16. J Clin Pharmacol. 2018 Oct;58(10):1254-1265 - PubMed
  17. Contrib Nephrol. 2007;156:191-6 - PubMed
  18. Blood Purif. 2013;35(4):279-84 - PubMed
  19. Int J Clin Pharm. 2018 Oct;40(5):1250-1256 - PubMed
  20. Semin Dial. 2016 Jul;29(4):278-80 - PubMed
  21. Sci Rep. 2019 Apr 29;9(1):6607 - PubMed
  22. Can J Kidney Health Dis. 2016 Jul 22;3:36 - PubMed
  23. Crit Care. 2011;15(3):R137 - PubMed
  24. Nutrition. 2003 Sep;19(9):733-40 - PubMed
  25. Contrib Nephrol. 2017;190:19-30 - PubMed
  26. Semin Dial. 2011 Mar-Apr;24(2):183-7 - PubMed
  27. Clin J Am Soc Nephrol. 2013 Aug;8(8):1284-91 - PubMed
  28. Am J Kidney Dis. 2015 Nov;66(5):884-930 - PubMed
  29. Clin Nephrol. 2012 Apr;77(4):329-31 - PubMed
  30. Int J Clin Pharm. 2016 Feb;38(1):127-34 - PubMed
  31. Chest. 1995 Jun;107(6):1662-4 - PubMed
  32. Blood Purif. 2016;42(3):238-47 - PubMed
  33. Intensive Care Med. 2012 Jan;38(1):20-8 - PubMed

Publication Types